DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cancer Biomarker Market Analysis By Type (Breast, Prostate, Colorectal, Cervical, Liver, Lung Cancer), By Biomolecule (Genetic, Epigenetic, Metabolic, Proteomic), By Application, And Segment Forecasts, 2014 - 2025" report to their offering.
The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025
Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.
In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.
People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.
Key Topics Covered:
1. Methodology and Scope
2. Executive Summary
3. Cancer Biomarkers Industry Outlook
4. Cancer Biomarkers Market: Type Outlook
5. Cancer biomarkers Market: Biomolecule Estimates & Trend Analysis
6. Cancer biomarkers Market: Application Estimates & Trend Analysis
7. Cancer Biomarkers Market: Regional Outlook
8. Company Profiles
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Qiagen N.V
- Affymetrix Inc
- Illumina, Inc
- Agilent Technologies
- Merck & Co. Inc
- Hologic, Inc.
- Sino Biological Inc.
- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
For more information about this report visit https://www.researchandmarkets.com/research/kvcw3q/cancer_biomarker